Skip to Content

WPI 3169 (Alendronate Sodium 5 mg)

Pill with imprint WPI 3169 is White, Round and has been identified as Alendronate Sodium 5 mg. It is supplied by Watson Pharmaceuticals, Inc..

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3169

Alendronate Sodium

Imprint
WPI 3169
Strength
5 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-3169

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.